173 related articles for article (PubMed ID: 17111253)
1. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
Aiello EJ; Buist DS; White E
Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
[TBL] [Abstract][Full Text] [Related]
2. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
Li CI; Malone KE; Daling JR
Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
[TBL] [Abstract][Full Text] [Related]
3. Prenatal and perinatal correlates of adult mammographic breast density.
Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
[TBL] [Abstract][Full Text] [Related]
4. Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use.
Carney PA; Kasales CJ; Tosteson AN; Weiss JE; Goodrich ME; Poplack SP; Wells WS; Titus-Ernstoff L
Prev Med; 2004 Jul; 39(1):48-55. PubMed ID: 15207985
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy use and mammographic density in postmenopausal Norwegian women.
Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G
Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for breast cancer associated with mammographic features in Singaporean chinese women.
Heng D; Gao F; Jong R; Fishell E; Yaffe M; Martin L; Li T; Stone J; Sun L; Hopper J; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1751-8. PubMed ID: 15533903
[TBL] [Abstract][Full Text] [Related]
8. Previous pregnancy outcome and breast density (United States).
El-Bastawissi AY; Aiello EJ; Buist DS; Taplin SH
Cancer Causes Control; 2005 May; 16(4):407-17. PubMed ID: 15953983
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy and breast cancer: what factors modify the association?
Gertig DM; Fletcher AS; English DR; Macinnis RJ; Hopper JL; Giles GG
Menopause; 2006; 13(2):178-84. PubMed ID: 16645531
[TBL] [Abstract][Full Text] [Related]
10. The relationship between mammographic density and duration of hormone therapy: effects of estrogen and estrogen-progestin.
Chen FP; Cheung YC; Teng LF; Soong YK
Hum Reprod; 2005 Jun; 20(6):1741-5. PubMed ID: 15845600
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen-progestin and estrogen on mammographic density.
Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and migraine headache.
Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Stuedal A; Ma H; Bjørndal H; Ursin G
Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk factors in relation to breast density (United States).
Titus-Ernstoff L; Tosteson AN; Kasales C; Weiss J; Goodrich M; Hatch EE; Carney PA
Cancer Causes Control; 2006 Dec; 17(10):1281-90. PubMed ID: 17111260
[TBL] [Abstract][Full Text] [Related]
16. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.
Crandall CJ; Karlamangla A; Huang MH; Ursin G; Guan M; Greendale GA
Arch Intern Med; 2006 Aug 14-28; 166(15):1578-84. PubMed ID: 16908790
[TBL] [Abstract][Full Text] [Related]
17. Factors that influence changes in mammographic density with postmenopausal hormone therapy.
Chen FP; Cheung YC; Soong YK
Taiwan J Obstet Gynecol; 2010 Dec; 49(4):413-8. PubMed ID: 21199741
[TBL] [Abstract][Full Text] [Related]
18. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
20. The role of mammographic density in evaluating changes in breast cancer risk.
Pike MC
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():1-5. PubMed ID: 16112948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
